Literature DB >> 10545769

Reactivity of T cells with grass pollen allergen extract and allergoid.

H Kahler1, H Stüwe, O Cromwell, H Fiebig.   

Abstract

BACKGROUND: Successful allergen-specific immunotherapy is achieved with progressively increasing doses of allergen or allergoid. In order to gain further insight into the mechanism of action of allergoids several in vitro investigations were conducted.
METHODS: Peripheral blood mononuclear cells (PBMC) from grass pollen allergic and nonallergic subjects were stimulated with either grass pollen extract or allergoid and the proliferation and cytokine production (IL-5, IFN-gamma) were measured. Similar investigations were performed with Phl p 5-specific T cell lines (TCL) and clones (TCC). Dendritic cells and PBMC were compared in terms of their relative efficacies as antigen-presenting cells.
RESULTS: Both allergen and allergoid induced proliferation and Th2 and Th1 cytokine synthesis by PBMC of allergic subjects, whereas PBMC of nonallergic subjects did not produce IL-5. The maximum level of IL-5 was obtained with a lower concentration than was necessary for maximal IFN-gamma production. Higher stimulation doses of allergen and allergoid shifted the cytokine profiles towards a Th1 phenotype. TCL and TCC clearly showed reactivity with both allergen and allergoid when using autologous PBMC for antigen presentation, but compared with the native allergen the reactivity of the allergoid was reduced with most of the TCC. Using dendritic cells for antigen presentation a pronounced increase of stimulation of the TCC especially for the allergoids becomes obvious.
CONCLUSION: In common with grass pollen allergen the corresponding allergoids possess a strong allergen-specific T cell-stimulating capacity. However, the degree of T cell stimulation by the allergoid seems to be dependent on the type of the antigen-presenting cell. Both, allergen and allergoid, can modulate T cell responses in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545769     DOI: 10.1159/000024233

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

Review 1.  [Immunotherapy with allergen extracts for allergic rhinitis].

Authors:  H Riechelmann
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

2.  Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cells.

Authors:  Bärbel Heydenreich; Iris Bellinghausen; Steffen Lorenz; Helene Henmar; Dennis Strand; Peter A Würtzen; Joachim Saloga
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

3.  Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.

Authors:  J A Asturias; A Ferrer; M C Arilla; C Andreu; B Madariaga; A Martínez
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  Ex Vivo Immunomodulatory Effects of Lactobacillus-, Lacticaseibacillus-, and Bifidobacterium-Containing Synbiotics on Human Peripheral Blood Mononuclear Cells and Monocyte-Derived Dendritic Cells in the Context of Grass Pollen Allergy.

Authors:  Alexander Heldner; Matthew D Heath; Benjamin Schnautz; Sebastian Kotz; Adam Chaker; Matthias F Kramer; Constanze A Jakwerth; Ulrich M Zissler; Carsten B Schmidt-Weber; Simon Blank
Journal:  Probiotics Antimicrob Proteins       Date:  2022-02-03       Impact factor: 4.609

5.  Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3.

Authors:  Zoe L Urry; David F Richards; Cheryl Black; Maria Morales; Jerónimo Carnés; Catherine M Hawrylowicz; Douglas S Robinson
Journal:  BMC Immunol       Date:  2014-05-29       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.